Seres Therapeutics, Inc. - (MCRB) share price
Seres Therapeutics, Inc. - (NASDAQ:MCRB) last traded at $1.98, down 5.26% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.02B and a 52-week range of $1.68 to $29.98.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $1.98 |
| 1-day move | -5.26% |
| 52-week range | $1.68 - $29.98 |
| Market cap | $0.02B |
| From 52-week high | -93.40% |
| Volume vs average | 1.2x |
| Falling Shares risk score | 42/100 (ELEVATED) |
| Country | United States |
Frequently asked questions
Why is Seres Therapeutics, Inc. - falling today?
Seres Therapeutics, Inc. - (NASDAQ:MCRB) is down 5.26% at its latest quote and trades 93.4% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Seres Therapeutics, Inc. - share price today?
Seres Therapeutics, Inc. - (NASDAQ:MCRB) last traded at $1.98, a -5.26% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Seres Therapeutics, Inc. -?
Seres Therapeutics, Inc. -'s 52-week low is $1.68 and its 52-week high is $29.98; the shares trade 93.4% below the high.
What is the market cap of Seres Therapeutics, Inc. -?
Seres Therapeutics, Inc. - has a market capitalisation of about $0.02B at the latest price.
What are the risks of investing in Seres Therapeutics, Inc. -?
Falling Shares Intelligence rates Seres Therapeutics, Inc. - 42/100 (ELEVATED) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com